Dilek Arslan Atessahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dilek Arslan Atessahin has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Lütfiye Kadıoğlu Dalkılıç
Fırat University, Faculty of Science, Department of Molecular Biology and Genetics, 23119
4 shared publications - Semih Dalkilic
Fırat University, Faculty of Science, Department of Molecular Biology and Genetics, 23119
4 shared publications - Abdullah Akman
Fırat University, Faculty of Science, Department of Molecular Biology and Genetics, 23119
2 shared publications - Rabia Yilmaz
Fırat University, Baskil Vocational School, Department of Plant and Animal Production, 23800, Elazig, Turkey
2 shared publications - Dilan Aşkın Özek
Firat Universitesi
1 shared publication - Dudu Bayindir
Firat University, Faculty of Science, Department of Molecular Biology and Genetics, Elazig, Türkiye
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 14 (9) , 2602-2611
Exploring the Therapeutic Properties of Elaeagnus angustifolia: A Study on Its Antimicrobial, Antioxidant, and Cytotoxic Effects
Malignant neoplasms, characterized by dysregulated cellular proliferation and immune evasion, remain a leading cause of global mortality. Plant-derived compounds have attracted increasing attention as potential therapeutic agents due to their lower toxicity profiles. This study aimed to evaluate the antimicrobial, antioxidant, and cytotoxic activity of methanol (EAM) and hexane (EAH) extracts of Elaeagnus angustifolia. Antimicrobial activity was assessed against Bacillus megaterium, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Candida albicans. The methanol extract exhibited the highest antimicrobial activity against K. pneumoniae, with an inhibition zone of 13 mm at 75 and 100 µg/mL. In B. megaterium, S. aureus, and C. albicans, inhibition zones increased in a concentration-dependent manner. Similarly, the hexane extract showed dose-dependent antimicrobial activity, with the largest inhibition zones observed at 100 µg/mL, particularly against B. megaterium and K. pneumoniae. Antioxidant activity was determined using the DPPH assay. The methanol extract demonstrated concentration-dependent free radical scavenging activity, reaching 28.6% inhibition at 100 µg/mL. Cytotoxic effects were evaluated in MCF-7 and HepG2 cell lines using the MTT assay. In MCF-7 cells, the methanol extract showed the highest cytotoxic activity at 200 µg/mL, with a 76% cell death rate, while higher concentrations (400 and 800 µg/mL) resulted in a marked reduction in cytotoxicity. The IC₅₀ value of the methanol extract in MCF-7 cells was 176.78 µg/mL. Treatment with EAM resulted in a statistically significant decrease in MCF-7 cell viability (p < 0.05), whereas EAH showed no significant effect. Neither extract exhibited significant cytotoxicity against HepG2 cells (p > 0.05). In conclusion, E. angustifolia extracts exhibit measurable antimicrobial, weak antioxidant, and selective cytotoxic activities, particularly against MCF-7 cells at lower concentrations, suggesting their potential as natural therapeutic agents.
- 17 September 2026
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 14 (9) , 2602-2611
Open AccessExploring the Therapeutic Properties of Elaeagnus angustifolia: A Study on Its Antimicrobial, Antioxidant, and Cytotoxic Effects
Malignant neoplasms, characterized by dysregulated cellular proliferation and immune evasion, remain a leading cause of global mortality. Plant-derived compounds have attracted increasing attention as potential therapeutic agents due to their lower toxicity profiles. This study aimed to evaluate the antimicrobial, antioxidant, and cytotoxic activity of methanol (EAM) and hexane (EAH) extracts of Elaeagnus angustifolia. Antimicrobial activity was assessed against Bacillus megaterium, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Candida albicans. The methanol extract exhibited the highest antimicrobial activity against K. pneumoniae, with an inhibition zone of 13 mm at 75 and 100 µg/mL. In B. megaterium, S. aureus, and C. albicans, inhibition zones increased in a concentration-dependent manner. Similarly, the hexane extract showed dose-dependent antimicrobial activity, with the largest inhibition zones observed at 100 µg/mL, particularly against B. megaterium and K. pneumoniae. Antioxidant activity was determined using the DPPH assay. The methanol extract demonstrated concentration-dependent free radical scavenging activity, reaching 28.6% inhibition at 100 µg/mL. Cytotoxic effects were evaluated in MCF-7 and HepG2 cell lines using the MTT assay. In MCF-7 cells, the methanol extract showed the highest cytotoxic activity at 200 µg/mL, with a 76% cell death rate, while higher concentrations (400 and 800 µg/mL) resulted in a marked reduction in cytotoxicity. The IC₅₀ value of the methanol extract in MCF-7 cells was 176.78 µg/mL. Treatment with EAM resulted in a statistically significant decrease in MCF-7 cell viability (p < 0.05), whereas EAH showed no significant effect. Neither extract exhibited significant cytotoxicity against HepG2 cells (p > 0.05). In conclusion, E. angustifolia extracts exhibit measurable antimicrobial, weak antioxidant, and selective cytotoxic activities, particularly against MCF-7 cells at lower concentrations, suggesting their potential as natural therapeutic agents.
- Open Access
- 17 September 2026
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 14 (9) , 2602-2611
Exploring the Therapeutic Properties of Elaeagnus angustifolia: A Study on Its Antimicrobial, Antioxidant, and Cytotoxic Effects
Malignant neoplasms, characterized by dysregulated cellular proliferation and immune evasion, remain a leading cause of global mortality. Plant-derived compounds have attracted increasing attention as potential therapeutic agents due to their lower toxicity profiles. This study aimed to evaluate the antimicrobial, antioxidant, and cytotoxic activity of methanol (EAM) and hexane (EAH) extracts of Elaeagnus angustifolia. Antimicrobial activity was assessed against Bacillus megaterium, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Candida albicans. The methanol extract exhibited the highest antimicrobial activity against K. pneumoniae, with an inhibition zone of 13 mm at 75 and 100 µg/mL. In B. megaterium, S. aureus, and C. albicans, inhibition zones increased in a concentration-dependent manner. Similarly, the hexane extract showed dose-dependent antimicrobial activity, with the largest inhibition zones observed at 100 µg/mL, particularly against B. megaterium and K. pneumoniae. Antioxidant activity was determined using the DPPH assay. The methanol extract demonstrated concentration-dependent free radical scavenging activity, reaching 28.6% inhibition at 100 µg/mL. Cytotoxic effects were evaluated in MCF-7 and HepG2 cell lines using the MTT assay. In MCF-7 cells, the methanol extract showed the highest cytotoxic activity at 200 µg/mL, with a 76% cell death rate, while higher concentrations (400 and 800 µg/mL) resulted in a marked reduction in cytotoxicity. The IC₅₀ value of the methanol extract in MCF-7 cells was 176.78 µg/mL. Treatment with EAM resulted in a statistically significant decrease in MCF-7 cell viability (p < 0.05), whereas EAH showed no significant effect. Neither extract exhibited significant cytotoxicity against HepG2 cells (p > 0.05). In conclusion, E. angustifolia extracts exhibit measurable antimicrobial, weak antioxidant, and selective cytotoxic activities, particularly against MCF-7 cells at lower concentrations, suggesting their potential as natural therapeutic agents.
- 17 September 2026
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 14 (9) , 2602-2611
Open AccessExploring the Therapeutic Properties of Elaeagnus angustifolia: A Study on Its Antimicrobial, Antioxidant, and Cytotoxic Effects
Malignant neoplasms, characterized by dysregulated cellular proliferation and immune evasion, remain a leading cause of global mortality. Plant-derived compounds have attracted increasing attention as potential therapeutic agents due to their lower toxicity profiles. This study aimed to evaluate the antimicrobial, antioxidant, and cytotoxic activity of methanol (EAM) and hexane (EAH) extracts of Elaeagnus angustifolia. Antimicrobial activity was assessed against Bacillus megaterium, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Candida albicans. The methanol extract exhibited the highest antimicrobial activity against K. pneumoniae, with an inhibition zone of 13 mm at 75 and 100 µg/mL. In B. megaterium, S. aureus, and C. albicans, inhibition zones increased in a concentration-dependent manner. Similarly, the hexane extract showed dose-dependent antimicrobial activity, with the largest inhibition zones observed at 100 µg/mL, particularly against B. megaterium and K. pneumoniae. Antioxidant activity was determined using the DPPH assay. The methanol extract demonstrated concentration-dependent free radical scavenging activity, reaching 28.6% inhibition at 100 µg/mL. Cytotoxic effects were evaluated in MCF-7 and HepG2 cell lines using the MTT assay. In MCF-7 cells, the methanol extract showed the highest cytotoxic activity at 200 µg/mL, with a 76% cell death rate, while higher concentrations (400 and 800 µg/mL) resulted in a marked reduction in cytotoxicity. The IC₅₀ value of the methanol extract in MCF-7 cells was 176.78 µg/mL. Treatment with EAM resulted in a statistically significant decrease in MCF-7 cell viability (p < 0.05), whereas EAH showed no significant effect. Neither extract exhibited significant cytotoxicity against HepG2 cells (p > 0.05). In conclusion, E. angustifolia extracts exhibit measurable antimicrobial, weak antioxidant, and selective cytotoxic activities, particularly against MCF-7 cells at lower concentrations, suggesting their potential as natural therapeutic agents.
- 29 June 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (3) , 427-437
Molecular Perspective on Pancreatic Cancers with a Focus on Genetics, Genomics, and Diagnostics
The pancreas stands out as a complicated organ vital for maintaining physiological balance with its exocrine and endocrine roles. It is aimed to present the genetic underpinnings of working basis of pancreas and its diseases with related biochemical pathways, especially with a focus on pancreatic cancers (PC). This article collects all current research and filters data about pancreatic biology and the molecular genetic backgrounds, and genomics pathways related pancreatic diseases. The pancreas has the highest number of different genetic disorders, which are always multifactorial. The pancreatic adenocarcinoma are particularly significant due to their rapid metastatic potential, extreme lethality, and surprising mortality rates. Various studies have revealed the different causes of the development of pancreatic cancers. And it is seen that it may be both a somatic and hereditary type of cancer. Some very important research has emphasised a substantial but insufficient network of gene-phenotype relationships for several mutations and susceptibility loci. This article collects the detailed perspective about existing literature to underline the molecular view of pancreatic cancers based on genetic, genomic and diagnostic principles. This article focus on isolated aspects such as genomics or diagnostics, this review provides an integrated perspective combining molecular genetics, genomic instability, and emerging diagnostic approaches. By synthesizing findings across multiple disciplines, this study highlights the importance of a systems-level understanding of pancreatic cancer and proposes a framework for future research directions.
- 29 June 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (3) , 427-437
Molecular Perspective on Pancreatic Cancers with a Focus on Genetics, Genomics, and Diagnostics
The pancreas stands out as a complicated organ vital for maintaining physiological balance with its exocrine and endocrine roles. It is aimed to present the genetic underpinnings of working basis of pancreas and its diseases with related biochemical pathways, especially with a focus on pancreatic cancers (PC). This article collects all current research and filters data about pancreatic biology and the molecular genetic backgrounds, and genomics pathways related pancreatic diseases. The pancreas has the highest number of different genetic disorders, which are always multifactorial. The pancreatic adenocarcinoma are particularly significant due to their rapid metastatic potential, extreme lethality, and surprising mortality rates. Various studies have revealed the different causes of the development of pancreatic cancers. And it is seen that it may be both a somatic and hereditary type of cancer. Some very important research has emphasised a substantial but insufficient network of gene-phenotype relationships for several mutations and susceptibility loci. This article collects the detailed perspective about existing literature to underline the molecular view of pancreatic cancers based on genetic, genomic and diagnostic principles. This article focus on isolated aspects such as genomics or diagnostics, this review provides an integrated perspective combining molecular genetics, genomic instability, and emerging diagnostic approaches. By synthesizing findings across multiple disciplines, this study highlights the importance of a systems-level understanding of pancreatic cancer and proposes a framework for future research directions.
- Open Access
- 10 January 2025
- Published by Bektas Tepe Publications in International Journal of Plant Based Pharmaceuticals
- Vol. 5 (1) , 25-32
Evaluation of cytotoxic, antimicrobial, and antioxidant activi-ties of Echium italicum L. in MCF-7 and HepG2 cell lines
The use of plants for medicinal purposes from past to present continues as traditional treatments. One of these plants, Echium species, is known for its high phytochemical content and its use as a sedative or in colds. In this study, the antibacterial, antioxidant and anticancer properties of Echium italicum L. were investigated. Its anticancer effect was tested in HepG2 (liver cancer) and MCF-7 (breast cancer) cell lines. Its antimicrobial effect was also investigated in Candida albicans, Klebsiella pneumoniae, Escherichia coli, Bacillus megaterium and Staphylococcus aureus. The results showed that the highest cytotoxic effect was observed in the HepG2 cell line with 23% dead cell count. This suggests that the plant is especially effective in liver cancer cell lines. It was found that the extract prepared in hexane had the largest inhibition zone diameter (15 mm) against C. albicans in terms of antibacterial activity. The highest DPPH radical scavenging activity was observed in methanol extract with 37.6%. Considering the IC50 value in DPPH, hexane extract exhibited better activity than methanol extract (IC50 = 20.7 µg/ml). The data obtained from the study indicate that E. italicum has cytotoxic, antimicrobial and antioxidant effects. It is thought that the present study may contribute to the development and design of new anticancer and antimicrobial drugs, especially in the field of cancer research and pharmacology. In addition, it was concluded that the studies on the medical potential of E. italicum should be expanded and more comprehensive studies should be conducted.
- 10 January 2025
- Published by Bektas Tepe Publications in International Journal of Plant Based Pharmaceuticals
- Vol. 5 (1) , 25-32
Open AccessEvaluation of cytotoxic, antimicrobial, and antioxidant activi-ties of Echium italicum L. in MCF-7 and HepG2 cell lines
The use of plants for medicinal purposes from past to present continues as traditional treatments. One of these plants, Echium species, is known for its high phytochemical content and its use as a sedative or in colds. In this study, the antibacterial, antioxidant and anticancer properties of Echium italicum L. were investigated. Its anticancer effect was tested in HepG2 (liver cancer) and MCF-7 (breast cancer) cell lines. Its antimicrobial effect was also investigated in Candida albicans, Klebsiella pneumoniae, Escherichia coli, Bacillus megaterium and Staphylococcus aureus. The results showed that the highest cytotoxic effect was observed in the HepG2 cell line with 23% dead cell count. This suggests that the plant is especially effective in liver cancer cell lines. It was found that the extract prepared in hexane had the largest inhibition zone diameter (15 mm) against C. albicans in terms of antibacterial activity. The highest DPPH radical scavenging activity was observed in methanol extract with 37.6%. Considering the IC50 value in DPPH, hexane extract exhibited better activity than methanol extract (IC50 = 20.7 µg/ml). The data obtained from the study indicate that E. italicum has cytotoxic, antimicrobial and antioxidant effects. It is thought that the present study may contribute to the development and design of new anticancer and antimicrobial drugs, especially in the field of cancer research and pharmacology. In addition, it was concluded that the studies on the medical potential of E. italicum should be expanded and more comprehensive studies should be conducted.
- Open Access
- 27 December 2024
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 21 (3) , 527-532
Nebivololün İsoproterenol İndüklü Kardiyak Hasarda Koruyuculuğu ve İrisinin Rolü
Amaç: Nebivolol (NEB), adrenoreseptör blokajı yaparken beraberinde damarlarda etkin bir gev-şeme sağlayan bir β blokördür. İrisin disfonksiyonunun hipertansiyon, koroner arter hastalığı, miyokard infarktüsü gibi kardiyovasküler hastalıklarda rolü olduğu bilinmektedir. Bu çalışmada isoproterenol (İSO) ile indüklenmiş kardiyak hasarda nebivolol tedavisinin, kahverengi yağ doku-sunun bol bulunduğu kardiyomiyositlerde etkin olduğu bilinen irisin, oksidatif stres göstergesi malondialdehit (MDA) ve miyokard hasarına bağlı kardiyomiyositlerden kana salınan kreatin kinaz miyokart bandı (CK-MB) seviyelerine etkilerinin değerlendirilmesi amaçlanmıştır. Materyal ve metod: 28 adet Sprague-Dawley erkek sıçan kontrol, ISO, ISO+NEB ve NEB grupları-na dağıtıldı. İsoproterenol 150 mg/kg subkutan 24 saat ara ile subkutan yolla 2 kez uygulandı, nebivolol 10 gün süreyle 10 mg/kg/gün gavaj yoluyla verildi. İrisin ve CK-MB ELISA, MDA ise spektrofotometrik yöntem ile ölçüldü. Bulgular: Serum CK-MB, kalp dokusu MDA ve serum irisin düzeyleri İSO indüklemesi ile anlamlı arttı. Nebivolol tedavisi ise her üç parametreyi de anlamlı şekilde azalttı (p<0.05). Sonuç: Daha ileri çalışmalara ihtiyaç olmakla beraber, irisinin İSO indüklü kardiyak hasarda ve nebivolol koruyuculuğunda rolü olabileceği düşünülmektedir.
- 27 December 2024
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 21 (3) , 527-532
Open AccessNebivololün İsoproterenol İndüklü Kardiyak Hasarda Koruyuculuğu ve İrisinin Rolü
Amaç: Nebivolol (NEB), adrenoreseptör blokajı yaparken beraberinde damarlarda etkin bir gev-şeme sağlayan bir β blokördür. İrisin disfonksiyonunun hipertansiyon, koroner arter hastalığı, miyokard infarktüsü gibi kardiyovasküler hastalıklarda rolü olduğu bilinmektedir. Bu çalışmada isoproterenol (İSO) ile indüklenmiş kardiyak hasarda nebivolol tedavisinin, kahverengi yağ doku-sunun bol bulunduğu kardiyomiyositlerde etkin olduğu bilinen irisin, oksidatif stres göstergesi malondialdehit (MDA) ve miyokard hasarına bağlı kardiyomiyositlerden kana salınan kreatin kinaz miyokart bandı (CK-MB) seviyelerine etkilerinin değerlendirilmesi amaçlanmıştır. Materyal ve metod: 28 adet Sprague-Dawley erkek sıçan kontrol, ISO, ISO+NEB ve NEB grupları-na dağıtıldı. İsoproterenol 150 mg/kg subkutan 24 saat ara ile subkutan yolla 2 kez uygulandı, nebivolol 10 gün süreyle 10 mg/kg/gün gavaj yoluyla verildi. İrisin ve CK-MB ELISA, MDA ise spektrofotometrik yöntem ile ölçüldü. Bulgular: Serum CK-MB, kalp dokusu MDA ve serum irisin düzeyleri İSO indüklemesi ile anlamlı arttı. Nebivolol tedavisi ise her üç parametreyi de anlamlı şekilde azalttı (p<0.05). Sonuç: Daha ileri çalışmalara ihtiyaç olmakla beraber, irisinin İSO indüklü kardiyak hasarda ve nebivolol koruyuculuğunda rolü olabileceği düşünülmektedir.
- Open Access
- 1 January 2023
- Published by International Journal of Nature and Life Sciences in International Journal of Nature and Life Sciences
- Vol. 7 (2) , 129-135
Investigation of Cytotoxic, Antimicrobial and Antioxidant Activity of Echium vulgare L. Seed
Echium vulgare L. is a plant belonging to the Boraginaceae family and is used in traditional medicine for the treatment of various diseases, especially known for its anti-inflammatory and antioxidant properties. The aim of this study was to determine the cytotoxic activity of different concentrations of E. vulgare L. seed extracts obtained from methanol and hexane solvents on human breast cancer (MCF7) and human liver cancer (HepG2) cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The antioxidant activity of the extract obtained from methanol and hexane at the same concentrations was determined according to the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging capacity method. Antimicrobial activity was determined by disk diffusion method and bacteria such as Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli and Bacillus megaterium and Candida albicans microorganisms as fungi were used for the study. The highest antibacterial activity was detected against Escherichia coli (E. coli) with a zone diameter of 16±4 mm. Seed extract of E. vulgare prepared with hexane showed the most effective cytotoxic activity on HepG2 cell line with 20% cytotoxicity rate. In antioxidant activity tests, the methanol extract of E. vulgare exhibited the highest activity with 4.5% reduction. In conclusion, seed extracts of E. vulgare appear to be a potential source for both anticancer and antimicrobial therapies.
- 1 January 2023
- Published by International Journal of Nature and Life Sciences in International Journal of Nature and Life Sciences
- Vol. 7 (2) , 129-135
Open AccessInvestigation of Cytotoxic, Antimicrobial and Antioxidant Activity of Echium vulgare L. Seed
Echium vulgare L. is a plant belonging to the Boraginaceae family and is used in traditional medicine for the treatment of various diseases, especially known for its anti-inflammatory and antioxidant properties. The aim of this study was to determine the cytotoxic activity of different concentrations of E. vulgare L. seed extracts obtained from methanol and hexane solvents on human breast cancer (MCF7) and human liver cancer (HepG2) cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The antioxidant activity of the extract obtained from methanol and hexane at the same concentrations was determined according to the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging capacity method. Antimicrobial activity was determined by disk diffusion method and bacteria such as Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli and Bacillus megaterium and Candida albicans microorganisms as fungi were used for the study. The highest antibacterial activity was detected against Escherichia coli (E. coli) with a zone diameter of 16±4 mm. Seed extract of E. vulgare prepared with hexane showed the most effective cytotoxic activity on HepG2 cell line with 20% cytotoxicity rate. In antioxidant activity tests, the methanol extract of E. vulgare exhibited the highest activity with 4.5% reduction. In conclusion, seed extracts of E. vulgare appear to be a potential source for both anticancer and antimicrobial therapies.
- 12 April 2021
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 44 (3) , 388-396
Pharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (Coturnix coturnix japonica)
The aim of this study was to determine the pharmacokinetics of meloxicam (MLX), carprofen (CRP), and tolfenamic acid (TA) in Japanese quails (Coturnix coturnix japonica) following intramuscular (IM) and oral administration at doses of 1, 10, and 2 mg/kg, respectively. A total of 72 quails were randomly divided into 3 equal groups as MLX, CRP, and TA. Each group was separated into two sub‐groups that received IM and oral administration of each drug. Plasma concentrations of MLX, CRP, and TA were determined using HPLC‐UV and analyzed by non‐compartmental method. The t1/2ʎzand MRT of MLX, CRP, and TA after oral administration were similar to those after IM administration. The Vdarea/F of MLX, CRP, and TA after IM administration was 0.28, 2.05, and 0.20 L/kg. The Cl/F of MLX, CRP, and TA after IM administration was 0.12, 0.19, and 0.09 L/h/kg. MLX, CRP, and TA after oral administration showed significantly lower Cmaxand longer Tmaxcompared with IM administration. The relative bioavailability of MLX, CRP, and TA following oral administration in quails was 76.13%, 61.46%, and 57.32%, respectively. The IM and oral route of MLX, CRP, and TA can be used for the treatment of various conditions in quails. However, further research is necessary to determine the pharmacodynamics and safety of MLX, CRP, and TA before use in quails.
- 12 April 2021
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 44 (3) , 388-396
Pharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (Coturnix coturnix japonica)
The aim of this study was to determine the pharmacokinetics of meloxicam (MLX), carprofen (CRP), and tolfenamic acid (TA) in Japanese quails (Coturnix coturnix japonica) following intramuscular (IM) and oral administration at doses of 1, 10, and 2 mg/kg, respectively. A total of 72 quails were randomly divided into 3 equal groups as MLX, CRP, and TA. Each group was separated into two sub‐groups that received IM and oral administration of each drug. Plasma concentrations of MLX, CRP, and TA were determined using HPLC‐UV and analyzed by non‐compartmental method. The t1/2ʎzand MRT of MLX, CRP, and TA after oral administration were similar to those after IM administration. The Vdarea/F of MLX, CRP, and TA after IM administration was 0.28, 2.05, and 0.20 L/kg. The Cl/F of MLX, CRP, and TA after IM administration was 0.12, 0.19, and 0.09 L/h/kg. MLX, CRP, and TA after oral administration showed significantly lower Cmaxand longer Tmaxcompared with IM administration. The relative bioavailability of MLX, CRP, and TA following oral administration in quails was 76.13%, 61.46%, and 57.32%, respectively. The IM and oral route of MLX, CRP, and TA can be used for the treatment of various conditions in quails. However, further research is necessary to determine the pharmacodynamics and safety of MLX, CRP, and TA before use in quails.